Adze Biotechnology Inc
Amendment
CIK: 0001787508·Biotechnology·DELAWARE·Filed: May 19, 2022
Total Offering
$3,687,500
Amount Sold
$3,687,500
Investors
19
First Sale
Dec 12, 2019
Offering Details
- Type
- Equity, Debt, Security to be Acquired
- Exemptions
- Rule 506(c)
- Entity Type
- Corporation
- Year Incorporated
- 2018
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Sidney Hopps | Related Person |
| Kenneth Templin | Related Person |
| Richard Schuler | Related Person |
| Patrick G. Sage, II | Related Person |
| Gabriel Raviv | Related Person |
Company
SEC Filing
0001787508-22-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free